Jeffrey Cranmer - Profile and Journalist Details

Find journalists that align with your industry, location and vision. Unlock Jeffrey Cranmer's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.

Get connected with journalists today
Jeffrey Cranmer

Jeffrey Cranmer

Verified

Executive Editor, BioCentury

San Carlos

Final Covers

Business , Finance , Retail , Consumer Behaviour , Digital Transformation , Innovation , Technology , Globalisation , Market Disruption , Sociodemographic Shifts

Doesn’t Cover

social media food trends, spirits

Journalist Type

Seniority Positions

Industries

Medium Formats

Content

Total articles 9

  • Portal launches to seed Chicago start-ups

    By Jeffrey Cranmer Verified| BioCentury Verified Having trouble accessing articles? Reset your cache. By Jeff Cranmer, Executive Editor | Mar 6, 2020 | 12:25 AM GMT Portal Innovations launched to seed life sciences, medtech and bioinformatics companies, with a focus on biotechs developing therapeutics, and plans to house the start-ups in Read the full 258 word articleUser Sign InSign in to your BioCentury account to access your content. Trial SubscriptionGet a two-week free trial subscription to BioCenturySIGN UP

    By Jeffrey Cranmer Verified · BioCentury

    Mar. 05, 2020

  • New Therapeutic Targets and Biomarkers: January 2019

    By Jeffrey Cranmer Verified| BioCentury Verified 1:37 PM Feb 14, 2019 by Jeff Cranmer Share Text Size A A A Print PDF New Therapeutic Targets and Biomarkers: January 2019Select top therapeutic targets and biomarkers covered by BioCentury or added to the BCIQ database during January.

    By Jeffrey Cranmer Verified · BioCentury

    Feb. 14, 2019

  • Portal launches to seed Chicago start-ups

    By Jeffrey Cranmer Verified| BioCentury Verified Having trouble accessing articles? Reset your cache. By Jeff Cranmer, Executive Editor | Mar 6, 2020 | 12:25 AM GMT Portal Innovations launched to seed life sciences, medtech and bioinformatics companies, with a focus on biotechs developing therapeutics, and plans to house the start-ups in Read the full 258 word articleUser Sign InSign in to your BioCentury account to access your content. Trial SubscriptionGet a two-week free trial subscription to BioCenturySIGN UP

    By Jeffrey Cranmer Verified · BioCentury

    Mar. 05, 2020

As seen in

Company Info

BioCentury

BioCentury Inc. is a biotechnology-focused business intelligence and analytics company based in Redwood City, California. With over 30 years of experience, it specializes in providing strategic insights and data analysis tailored to the biopharma and biotech industries. The company reported a revenue of $16.2 million. BioCentury offers the BCIQ platform, which includes modules for tracking companies, products, and financial data. This platform helps clients identify trends, partnerships, and investment opportunities. Additionally, BioCentury provides analytical content that includes market trend analysis, visual data tools, and expert interviews. The company also facilitates networking through exclusive events and workshops, connecting C-suite executives and investors within the biopharma community.

'+1 650-595-5333

Founded: 1992